CAS 61596-53-0

pre-liposomes formulation 1

Description:

Pre-liposomes formulation 1, identified by the CAS number 61596-53-0, is a type of lipid-based delivery system designed to encapsulate and transport therapeutic agents, particularly in pharmaceutical applications. This formulation typically consists of phospholipids and other excipients that facilitate the formation of liposomes upon hydration. The characteristics of pre-liposomes include their ability to enhance the solubility and stability of hydrophobic drugs, improve bioavailability, and provide controlled release profiles. They are often characterized by their size, which can range from nanometers to micrometers, and their surface charge, which influences their interaction with biological membranes. Additionally, pre-liposomes can be tailored to achieve specific release kinetics and targeting capabilities, making them versatile for various drug delivery applications. The formulation is generally stable under dry conditions and requires hydration to form liposomes, which can then encapsulate active pharmaceutical ingredients. Overall, pre-liposomes represent a promising approach in the field of drug delivery systems.

Formula: C₄₈H₉₆NO₈P

3,5,9-Trioxa-4-phosphanonacosan-1-aminium,4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoeicosyl)oxy]-, inner salt,4-oxide, (7R)-

CAS: 61596-53-0

Formula: C₄₈H₉₆NO₈P

Purity: 98%

Color and Shape: Solid

Molecular weight: 846.2515

Ref: IN-DA00IAW7

(R)-2,3-Bis(icosanoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate

CAS: 61596-53-0

(R)-2,3-Bis(icosanoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate

Purity: 98%

Molecular weight: 846.27g/mol

Ref: 54-OR1067498

1,2-Diarachidoyl-sn-Glycero-3-Phosphatidylcholine

CAS: 61596-53-0

Formula: C48H96NO8P

Purity: >99%

Color and Shape: Solid

Molecular weight: 846.25

Ref: 48-37-2000

1,2-Diarachidoyl-sn-glycero-3-phosphocholine

CAS: 61596-53-0

1,2-Diarachidoyl-sn-glycero-3-phosphocholine is a polyunsaturated fatty acid that belongs to the group of phospholipids. It is found in plasma samples and has been shown to be involved in the regulation of cellular physiology. This compound has been identified as a potential marker for cardiovascular disease through its ability to reduce the risk of heart attack or stroke. The 1,2-diarachidoyl-sn-glycero-3-phosphocholine molecule contains two acyl chains, which are linked by ester bonds, and hydroxyl groups on either end of the molecule. The molecular modeling studies have revealed that this compound can exist in three conformations: bent (A), linear (B), or extended (C). In this study, it was found that conformational A was most prevalent in both hydrated and nonhydrated states.

Formula: C₄₈H₉₆NO₈P

Purity: Reported

Molecular weight: 846.28 g/mol

Ref: 3D-FD172067

1,2-Diarachidoyl-sn-glycero-3-phosphocholine

CAS: 61596-53-0

1,2-Diarachidoyl-sn-glycero-3-phosphocholine (DAGPC) is a phospholipid compound that plays a crucial role in various biological processes. It acts as an interfacial agent, forming a protein complex at the cell membrane. DAGPC has been studied extensively in relation to breast cancer, cardiac health, diabetes, and other conditions. In experiments conducted on animals and human subjects, it has been shown to have potential benefits in regulating angiotensin-converting enzyme activity, supporting myocardial function, and controlling glucagon levels. Additionally, DAGPC has demonstrated promising effects in castration-induced prostate cancer models. Its unique properties make it a valuable compound for further research and potential therapeutic applications.

Formula: C₄₈H₉₆NO₈P

Molecular weight: 846.28 g/mol

Ref: 3D-D-1422